Leptin
PreclinicalSmall molecule
Leptin is one of 5 small molecule programs targeting Homeostasis. It is currently in Preclinical.
1
Indications
11
Total Trials
0
Active Trials
4
Competitors
Pipeline
Status by Indication[3][1]
Indication
Competition
Competitive Landscape
6 competitors in Homeostasis
#DrugCompanyPhaseTrials
1Glucophage
EMD SeronoApproved
JYNNEOS
NNational Institute of Allergy and Infectious Diseases (NIAID)
Phase 3
Isonep
JJiangsu Nhwa Pharmaceutical Co., Ltd.
Phase 3
Leptin
UUniversity of Texas Southwestern Medical Center
Preclinical
Aldosterone
YYale University
Preclinical
Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.
Clinical
Trials by Indication[1]
Lipodystrophy2 trials
Homeostasis1 trial
Leptin in Human Energy and Neuroendocrine Homeostasis
Terminated·—·N/A·NCT00265980·22 enrolled
Obese1 trial
Low-Dose Leptin and the Formerly-Obese
Unknown status·NNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)·Phase 3·NCT00073242·25 enrolled
Gastric1 trial
Trial of Leptin Administration After Roux-en-Y Gastric Bypass
Completed·—·Phase 1/2·NCT00710814·31 enrolled
5 more indications
Body Weight1 trial
Leptin in the Maintenance of Reduced Body Weight
Completed·—·Phase 2·NCT01155180·24 enrolled
Humans1 trial
In Vivo Leptin Signaling in Humans After Acute Leptin Administration
Completed·—·Phase 1·NCT01275053·12 enrolled
Metabolic Syndrome1 trial
Combination of Insulin Sensitizer and Leptin as Treatment for the HAART -Induced Metabolic Syndrome
Completed·—·Phase 2·NCT00362440·9 enrolled
Sources
References
- [1]
- [2]
- [3]Open Targets Platform — Drug–disease associations for Leptin. EMBL-EBI & Wellcome Sanger Institute.
- [4]
Details